Wordt geladen...
A Substantial Response from Adding Palbociclib to Endocrine Therapy in Brain Metastasis from Hormone Receptor-Positive, HER2-Negative Breast Cancer: Case Reports
Brain metastasis (BM) from breast cancer has poor prognosis despite new advances and multi-modality treatments. No current data is guiding the use of palbociclib in the management of hormone receptor (HR)-positive breast cancer patients with BM as these patients were excluded systematically from all...
Bewaard in:
| Gepubliceerd in: | Case Rep Oncol |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983625/ https://ncbi.nlm.nih.gov/pubmed/33790765 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000514190 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|